Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Retained Earnings (2020 - 2025)

BioAtla (BCAB) has disclosed Retained Earnings for 6 consecutive years, with -$545.6 million as the latest value for Q4 2025.

  • For Q4 2025, Retained Earnings fell 12.25% year-over-year to -$545.6 million; the TTM value through Dec 2025 reached -$545.6 million, down 12.25%, while the annual FY2025 figure was -$545.6 million, 12.25% down from the prior year.
  • Retained Earnings hit -$545.6 million in Q4 2025 for BioAtla, down from -$535.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$109.6 million in Q1 2021 and bottomed at -$545.6 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$352.5 million, with a median of -$372.6 million recorded in 2023.
  • Year-over-year, Retained Earnings plummeted 104.93% in 2021 and then fell 12.25% in 2025.
  • BioAtla's Retained Earnings stood at -$186.3 million in 2021, then plummeted by 57.15% to -$292.8 million in 2022, then tumbled by 42.17% to -$416.3 million in 2023, then decreased by 16.76% to -$486.0 million in 2024, then decreased by 12.25% to -$545.6 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$545.6 million, -$535.9 million, and -$520.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.